CryoPort Company Profile (OTCMKTS:CYRX)

About CryoPort (OTCMKTS:CYRX)

CryoPort logoCryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company's Cryoport Express Solution includes a cloud-based logistics operating platform, which is branded as the Cryoportal. The Company's Cryoport Express Solutions are made up of the Cryoportal software platform, Cryoport Express Shippers, Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company, its clients and its business partners to automate the entry of orders, prepare customs documentation, and to facilitate status and location monitoring of shipped orders while in transit.

Industry, Sector and Symbol:
  • Sector: Industrials
  • Industry: Marine Logistics
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:CYRX
  • CUSIP: N/A
  • Web:
  • Market Cap: $193.69 million
  • Outstanding Shares: 24,674,000
Average Prices:
  • 50 Day Moving Avg: $8.92
  • 200 Day Moving Avg: $5.66
  • 52 Week Range: $1.80 - $10.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.90
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $10.32 million
  • Price / Sales: 18.77
  • Book Value: $0.63 per share
  • Price / Book: 12.46
  • EBITDA: ($6,680,000.00)
  • Net Margins: -63.77%
  • Return on Equity: -48.00%
  • Return on Assets: -41.35%
  • Average Volume: 276,069 shs.
  • Short Ratio: 2.1

Frequently Asked Questions for CryoPort (OTCMKTS:CYRX)

What is CryoPort's stock symbol?

CryoPort trades on the OTCMKTS under the ticker symbol "CYRX."

How were CryoPort's earnings last quarter?

CryoPort Inc (OTCMKTS:CYRX) announced its quarterly earnings results on Monday, August, 15th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.09. The business had revenue of $1.90 million for the quarter, compared to the consensus estimate of $1.43 million. CryoPort had a negative return on equity of 48.00% and a negative net margin of 63.77%. View CryoPort's Earnings History.

Where is CryoPort's stock going? Where will CryoPort's stock price be in 2017?

2 brokers have issued twelve-month price objectives for CryoPort's shares. Their predictions range from $4.50 to $5.50. On average, they expect CryoPort's stock price to reach $5.00 in the next twelve months. View Analyst Ratings for CryoPort.

Who are some of CryoPort's key competitors?

Who are CryoPort's key executives?

CryoPort's management team includes the folowing people:

  • Richard G. Rathmann, Independent Chairman of the Board
  • Jerrell W. Shelton, President, Chief Executive Officer, Director
  • Robert Steven Stefanovich, Chief Financial Officer, Treasurer, Corporate Secretary, IR Contact Officer
  • Robert J. Hariri M.D., Ph.D., Director
  • Richard J. Berman J.D., Independent Director
  • Ramkumar Mandalam Ph.D., Independent Director
  • Edward J. Zecchini, Independent Director

How do I buy CryoPort stock?

Shares of CryoPort can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CryoPort's stock price today?

One share of CryoPort stock can currently be purchased for approximately $7.85.

MarketBeat Community Rating for CryoPort (OTCMKTS CYRX)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  63
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CryoPort (OTCMKTS:CYRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00
Consensus Price Target History for CryoPort (OTCMKTS:CYRX)
Price Target History for CryoPort (OTCMKTS:CYRX)
Analysts' Ratings History for CryoPort (OTCMKTS:CYRX)
DateFirmActionRatingPrice TargetDetails
6/16/2017Cowen and CompanyInitiated CoverageOutperform$5.50View Rating Details
6/1/2017Needham & Company LLCBoost Price TargetBuy$3.50 -> $4.50View Rating Details
2/12/2016AegisLower Price TargetBuy$8.00 -> $4.00View Rating Details
(Data available from 10/21/2015 forward)


Earnings History for CryoPort (OTCMKTS:CYRX)
Earnings by Quarter for CryoPort (OTCMKTS:CYRX)
Earnings History by Quarter for CryoPort (OTCMKTS CYRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016Q217($0.16)($0.14)$1.90 million$2.00 millionViewN/AView Earnings Details
8/15/2016Q117($0.19)($0.28)$1.43 million$1.90 millionViewListenView Earnings Details
6/27/2016Q416($0.02)($0.26)$1.60 millionViewN/AView Earnings Details
2/8/2016Q316($0.28)($0.42)$2.20 millionViewN/AView Earnings Details
8/6/2015Q116($0.44)($0.42)$1.40 millionViewN/AView Earnings Details
2/5/2015($0.02)($0.03)ViewN/AView Earnings Details
11/13/2014($0.02)($0.05)ViewN/AView Earnings Details
8/1/2014($0.02)($0.05)ViewN/AView Earnings Details
5/20/2014($0.02)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CryoPort (OTCMKTS:CYRX)
Current Year EPS Consensus Estimate: $-0.72 EPS
Next Year EPS Consensus Estimate: $-0.72 EPS


Dividend History for CryoPort (OTCMKTS:CYRX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for CryoPort (OTCMKTS:CYRX)
Insider Trades by Quarter for CryoPort (OTCMKTS:CYRX)
Insider Trades by Quarter for CryoPort (OTCMKTS:CYRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2016Jerrell SheltonCEOBuy1,000$1.99$1,990.00View SEC Filing  
8/19/2016Robert StefanovichCFOBuy1,000$1.95$1,950.00View SEC Filing  
8/18/2016Jerrell SheltonCEOBuy7,000$1.88$13,160.00View SEC Filing  
11/20/2015Jerrell SheltonCEOBuy6,000$2.32$13,920.00View SEC Filing  
8/26/2015Jerrell SheltonCEOBuy12,000$2.90$34,800.00View SEC Filing  
8/14/2015Jerrell SheltonCEOBuy23,500$3.09$72,615.00View SEC Filing  
2/11/2015Jerrell SheltonCEOBuy2,400$0.56$1,344.00View SEC Filing  
11/25/2014Jerrell SheltonCEOBuy3,400$0.47$1,598.00View SEC Filing  
11/20/2014Jerrell SheltonCEOBuy10,800$0.40$4,320.00View SEC Filing  
11/18/2014Jerrell SheltonCEOBuy9,836$0.43$4,229.48View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CryoPort (OTCMKTS:CYRX)
Latest Headlines for CryoPort (OTCMKTS:CYRX)
DateHeadline logoETFs with exposure to CryoPort, Inc. : October 16, 2017 - October 16 at 6:26 PM logoETFs with exposure to CryoPort, Inc. : October 2, 2017 - October 3 at 7:37 AM logoCYRX Crosses Above Average Analyst Target - September 25 at 11:58 AM logoETFs with exposure to CryoPort, Inc. : September 19, 2017 - September 19 at 5:43 PM logoCryoPort, Inc. :CYRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 - September 18 at 5:41 PM logoCYRX: Raising Price Target on CAR-T Opportunity - August 16 at 6:06 PM logoCryoport Launches - Cryoport. Certified. Cool. - August 15 at 6:27 PM logoCRYOPORT's (CYRX) CEO Jerry Shelton on Q2 2017 Results - Earnings Call Transcript - August 12 at 5:10 PM logoCryoport Revenue Up 52% for the Second Quarter of 2017, Driven by Biopharma - August 8 at 5:28 PM logoFeatured Company News – Novartis Ropes in Cryoport for a Three-Year Contract to Provide Cryogenic Logistics Support for Commercialization of CTL019/CD19 CAR-T Cell Therapy - July 27 at 6:05 PM logoCryoport to Support Launch of Potential Treatment for Relapsed/Refractory Acute Lymphoblastic Leukemia - July 25 at 5:41 PM logoCryoPort, Inc. :CYRX-US: Earnings Analysis: Q1, 2017 By the Numbers : July 21, 2017 - July 21 at 7:26 PM logoFDA Panel Votes To Approve CTL019, Positive Implications for CYRX - July 19 at 6:53 PM logoCryoport Continues to Strengthen Sales Team with Appointments of Colin Coffua as Vice President, Strategic Accounts and John Phillips as Executive Director, Consulting Services - July 13 at 7:03 PM logoCryoport Announces Pricing of Public Offering of Common Stock - March 28 at 12:19 PM logoCryoPort's stock tumbles on heavy volume after share offering prices at deep discount - March 28 at 12:19 PM logoQ4 2016 Cryoport Inc Earnings Release - After Market Close - March 13 at 12:16 PM logoCryoport (CYRX) Announces its Validated cCyogenic Logistics Solutions are Supporting Gradalis Clinical Trials - January 3 at 6:22 PM logoCryoport Supports Gradalis' Vigil® Platform in Clinical Trials for Autologous Immunotherapies for Multiple Cancers - January 3 at 12:37 PM logo8:32 am CryoPort announces its validated cryogenic logistics solutions are supporting Gradalis clinical trials to evaluate its investigational Vigil engineered autologous tumor cell cellular immunotherapy tech for use in cancer treatments - January 3 at 12:37 PM logoCRYOPORT, INC. Files SEC form 10-Q, Quarterly Report - November 15 at 7:01 AM logoQ2 2017 Cryoport Inc Earnings Release - After Market Close - November 14 at 8:18 AM logoCRYOPORT, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Mat - September 24 at 9:13 AM logoCryoport (CYRX), Heat Biologics (HTBX), KCAS Commence Temperature Impact on Biomarkers Study - August 30 at 5:58 AM logoCRYOPORT, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements and Exhibits - August 16 at 9:48 PM logoQ1 2017 Cryoport Inc Earnings Release - After Market Close - August 15 at 11:48 AM logoCRYOPORT, INC. Files SEC form 8-K, Regulation FD Disclosure - August 2 at 10:06 PM logoCRYOPORT, INC. Files SEC form 10-K, Annual Report - June 28 at 3:52 PM logoCryoPort (CYRX) Gains as Losses Loom - June 28 at 9:25 AM logoCryoport Reports 50% Revenue Growth for Fiscal Year 2016 - June 28 at 9:25 AM



CryoPort (CYRX) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.